← Back to Search

Nonsteroidal Anti-inflammatory Drug

IV meloxicam for Total Knee Arthroplasty

Phase 3

Waitlist Available

Led By Victor H Hernandez, MD

Research Sponsored by University of Miami

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 2 hours, 24 hours

Awards & highlights

Study Summary

This trial is testing whether meloxicam can be used instead of ketorolac to manage pain after hip or knee surgery, and whether this change leads to less opioid use.

Eligible Conditions

Total Knee Arthroplasty
Total Hip Replacement

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 2 hours, 24 hours

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~2 hours, 24 hours

This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 hours, 24 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in pain score

Secondary outcome measures

Change in Opioid Consumption

Change in patient nausea scores and vomiting scores

Duration of hospital stay

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: IV meloxicam groupExperimental Treatment2 Interventions

Participants will be given IV meloxicam for pain management post total knee and hip arthroplasty.

Group II: Ketorolac groupActive Control2 Interventions

Participants will receive the institution specific joint replacement pain protocol.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Institution specific joint replacement pain protocol

2022

Completed Phase 3

~240

IV meloxicam

2022

Completed Phase 3

~240

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of MiamiLead Sponsor

899 Previous Clinical Trials

409,501 Total Patients Enrolled

Victor H Hernandez, MDPrincipal InvestigatorUniversity of Miami

1 Previous Clinical Trials

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this a blind or double-blind study?

"That is correct, the trial information available on clinicaltrials.gov suggests that this research is actively recruiting patients. The study was first advertised on May 1st, 2022 and has since been edited November 7th of the same year. They are looking for 200 individuals to participate at a single location."

Answered by AI

How many individuals are involved in this experiment?

"That is correct. The listing on clinicaltrials.gov specifies that this research study is open for recruitment. This trial was first announced on May 1st, 2022 and has since been updated on November 7th, 2022. The goal is to have 200 participants at a single location."

Answered by AI